ST SEBASTIAN’S
Issue I - St. Sebastian's School
Issue I - St. Sebastian's School
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SCIENCE<br />
The Road to Novartis<br />
Matt LaMarche '93 describes the journey from the classrooms at St. Sebastian's to the<br />
laboratory of Novartis.<br />
By Dan Tobin<br />
Germs… they’re everywhere. They wait to attack us when<br />
we least expect it. They cause us to cough, to sneeze, and<br />
to run a fever. They sap us of our energy and our appetite.<br />
If we’re lucky, our immune system kicks into high gear and, in a<br />
day or two, beats back the viruses and bacteria that have set up<br />
shop in our bodies.<br />
Sometimes, however, the grasp on our system is too much for<br />
our bodies to handle and we need to call in reinforcements to help in<br />
our fight against the invaders. In these cases, we rely on the<br />
experience of our doctors, the men and women who have a treasure<br />
chest of pills and potions at their disposal.<br />
But, from where do those pills and potions come?<br />
Matt LaMarche ’93 can answer that one.<br />
What He Does<br />
Matt LaMarche is a Medicinal Chemist and Project Team Leader<br />
for Novartis Institutes for Biomedical Research in Cambridge.<br />
“I’m in drug discovery research,” stated LaMarche. “I’m a<br />
research chemist who identifies compounds that are drug<br />
candidates. Right now I am working in infectious disease, medicinal<br />
chemistry.”<br />
More specifically, LaMarche’s team is currently working on an<br />
anti-viral project for Hepatitis C. As Team Leader for the project, he<br />
has to identify the strategy and how the team is going to attack the<br />
disease. Basically, there is a protein target they are trying to<br />
modulate with small molecules. LaMarche is responsible for the<br />
chemistry strategy and the overall project strategy for how the team<br />
will modulate the target to affect the disease.<br />
“Part of my job is to run the lab,” LaMarche commented. “I<br />
oversee two medicinal chemists who execute reactions and<br />
purifications in the lab. They combine chemicals in organic<br />
synthesis reactions to make more complex molecules, then purify<br />
those materials and submit them to our biologists, who measure<br />
whether or not the compounds have the desired biological activity or<br />
not.”<br />
As the Team Leader, LaMarche is there to help with the<br />
optimization of those reactions and purifications. He is also<br />
Matt LaMarche with his wife, Ellen, and their children, Julia and<br />
Madeline.<br />
38 | <strong>ST</strong>. SEBA<strong>ST</strong>IAN’S MAGAZINE Volume V, Issue I